ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

JNJ Johnson and Johnson

148.80
0.27 (0.18%)
Pre Market
Last Updated: 07:51:44
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,870
Bid Price
Ask Price
News -
Day High

Low
143.13

52 Week Range

High
175.97

Day Low
Company Name Stock Ticker Symbol Market Type
Johnson and Johnson JNJ NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.27 0.18% 148.80 07:51:44
Open Price Low Price High Price Close Price Prev Close
148.53
Trades Volume Avg Volume 52 Week Range
103 1,870 - 143.13 - 175.97
Last Trade Time Type Quantity Stock Price Currency
07:51:44 5 $ 148.92 USD

Johnson and Johnson (JNJ) Options Flow Summary

Overall Flow

Bearish

Net Premium

-22M

Calls / Puts

70.77%

Buys / Sells

94.12%

OTM / ITM

32.14%

Sweeps Ratio

0.03%

Johnson and Johnson Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
357.77B 2.41B - 85.16B 35.15B 14.59 10.18
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Johnson and Johnson News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No JNJ Message Board. Create One! See More Posts on JNJ Message Board See More Message Board Posts

Historical JNJ Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week144.98150.49143.13148.189,918,9713.822.63%
1 Month158.11159.14143.13149.817,948,376-9.31-5.89%
3 Months158.07163.11143.13155.407,645,338-9.27-5.86%
6 Months151.24163.58143.13155.227,203,059-2.44-1.61%
1 Year164.31175.97143.13162.6911,009,420-15.51-9.44%
3 Years165.21186.69143.13166.008,440,856-16.41-9.93%
5 Years138.52186.69109.16157.528,158,67410.287.42%

Johnson and Johnson Description

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States.

Your Recent History

Delayed Upgrade Clock